DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Loibl S, von Minckwitz G, Schneeweiss A. et al.
PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer.
J Clin Oncol 2014;
32: 3212-3220
We do not assume any responsibility for the contents of the web pages of other providers.